The inMIND trial led to the FDA approval of Monjuvi with Revlimid and Rituxan for relapsed follicular lymphoma, showing ...

In his career, Emmerich has enlisted science, in very loose terms, to tell large-scale stories about wormholes in time and ...

Jordan Lasker, known online as Crémieux, is taking a victory lap after he was mentioned by The New York Times.

Reactions that alter organic scaffolds by a single atom are already proving useful, but time will tell if they’ll ...

A trove of periodicals is available for anyone to peruse at Library180, a project by two printheads who met as interns at a ...

Scientists at MIT have turbocharged one of nature’s most sluggish but essential enzymes—rubisco—by applying a cutting-edge ...